耐药结核病流行现状及抗结核药物研究进展(4)
[8] Sacks LV， Behrman RE. Challenges， successes and hopes in the development of novel TB therapeutics [J]. Future Med Chem， 2009， 1(4)： 749-756.[9] Haagsma AC， Podasca I， Koul A， et al. Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase [J]. PLoS One ......
您现在查看是摘要页，全文长 2731 字符。